Literature DB >> 7813552

An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.

M K Pugsley1, D A Saint, M J Walker.   

Abstract

This study examined the actions of the selective kappa-opioid receptor agonist, U-50,488H, on voltage activated Na+ and K+ currents in isolated rat cardiac myocytes. U-50,488H produced a concentration-dependent block of the transient Na+ current with an ED50 of about 15 microM, and, at higher concentrations (40-50 microM), a block of the plateau K+ current and an increase in the rate of decay of the transient K+ current. In addition U-50,488H produced a hyperpolarising shift in the inactivation curve for the transient Na+ current without altering the voltage dependence for activation and without an effect on the voltage dependence of inactivation or activation of K+ currents. The block of Na+ currents by U-50,488H showed pronounced use dependence. The kappa-opioid receptor antagonist MR2266 did not itself produce any change in the Na+ or K+ currents and did not change the channel blocking properties of U-50,488H. Thus, since the antiarrhythmic actions of U-50,488H are not blocked by MR2266 or naloxone, the effects of U-50,488H to block Na+ and K+ currents are the most likely reasons for its antiarrhythmic actions, rather than an action at kappa-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813552     DOI: 10.1016/0014-2999(94)90121-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist.

Authors:  M K Pugsley; E J Yu; A L Goldin
Journal:  Exp Clin Cardiol       Date:  2001

2.  Molecular analysis of the Na+ channel blocking actions of the novel class I anti-arrhythmic agent RSD 921.

Authors:  M K Pugsley; A L Goldin
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.

Authors:  Liang Cheng; Sai Ma; Long-Xiao Wei; Hai-Tao Guo; Lu-Yu Huang; Hui Bi; Rong Fan; Juan Li; Ya-Li Liu; Yue-Min Wang; Xin Sun; Quan-Yu Zhang; Shi-Qiang Yu; Ding-Hua Yi; Xin-Liang Ma; Jian-Ming Pei
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

4.  The κ-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons.

Authors:  Bassil Hassan; Victor Ruiz-Velasco
Journal:  Reg Anesth Pain Med       Date:  2013 Jan-Feb       Impact factor: 6.288

5.  Modulation of the induction of ornithine decarboxylase by some opioid receptor agonists in immune cells and cardiomyocytes.

Authors:  C Pignatti; I Stanic; C Stefanelli; B Tantini; C Rossoni; F Flamigni
Journal:  Mol Cell Biochem       Date:  1998-08       Impact factor: 3.396

6.  Sex differences in U50,488H-induced phosphorylation of p44/42 mitogen-activated protein kinase in the guinea pig brain.

Authors:  K Rasakham; K L McGillivray; L-Y Liu-Chen
Journal:  Neuroscience       Date:  2012-07-31       Impact factor: 3.590

Review 7.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.

Authors:  Leonid N Maslov; Igor Khaliulin; Peter R Oeltgen; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown; Yury B Lishmanov; James M Downey
Journal:  Med Res Rev       Date:  2016-05-16       Impact factor: 12.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.